Attovia Therapeutics Inc. logo

Attovia Therapeutics Inc.

ATTO | NASDAQ
Chart Builder DCF Calculator
$21.30
-$0.84 (-3.79%)
At close: Sep 21, 2026, 4:00 PM ET

Market Data

Market Cap
$952.68M
Enterprise Value
$805.73M
Beta
0.00
Average Volume
463.67K
Shares Outstanding (Diluted)
45.65M
Shares Change YoY
N/A
Institutional Ownership
N/A
Exchange
NASDAQ
ISIN
US04987L1026

Price Performance

Price Change 1M
5.4%
Price Change 3M
-2.7%
Price Change 6M
-2.7%
Price Change YTD
-2.7%
Price Change 1Y
-2.7%
Price Change 3Y
5.6%
Price Change 5Y
5.6%
1M CAGR (ann.)
8.6%
1Y CAGR (ann.)
N/A
5Y CAGR (ann.)
N/A
All-Time CAGR
9.5%

Valuation

PE Ratio
-22.90
Forward PE
N/A
PEG Ratio
0.29
Forward PEG
0.58
PS Ratio
2,036.75
Forward PS
678.90
PB Ratio
8.13
P/FCF Ratio
-25.97
P/Adj. FCF Ratio
-25.97
P/OCF Ratio
-27.66
EV/Sales
1,790.52
EV/EBIT
-19.30
EV/EBITDA
-19.52
EV/FCF
-22.83
Earnings Yield
-4.4%
FCF Yield
-3.9%
Adj. FCF Yield
-3.9%

Financial Health

Net Cash
$113.09M
Total Debt
$4.33M
Cash & Short-Term Investments
$115.13M
Total Assets
$128.35M
Current Ratio
9.39
Quick Ratio
9.39
Debt / Equity Ratio
0.04
Debt / EBITDA
-0.10
Debt / FCF
-0.12
OCF / Debt
-8.07
Interest Coverage
0.00
Altman Z-Score
34.97
Piotroski F-Score
1

Margins & Profitability

Gross Profit Margin
-8.4%
Operating Profit Margin
-9279.6%
EBITDA Margin
-9171.1%
Net Profit Margin
-8742.9%
FCF Margin
-7842.9%
Adj. FCF Margin
-7842.9%
SBC / Revenue
0.0%
SBC Impact (per share)
N/A

Returns

Return on Assets
-30.6%
Return on Equity
-32.0%
Return on Invested Capital
-35.5%
Return on Capital Employed
-36.1%
Return on Tangible Assets
-30.6%

Analyst Forecasts

Analyst Rating
Hold
Analyst Count
0
EPS Growth Next 3Y
N/A
Revenue Growth Next 3Y
N/A
Earnings Date
Sep 1, 2026
EPS Estimate (next Q)
-$0.65
EPS Growth Est (next Q)
N/A
Revenue Est (next Q)
$316.67K
Revenue Growth Est (next Q)
N/A

Fair Value Estimates

Graham Number
N/A
Graham Upside
N/A
Lynch Fair Value
N/A
Lynch Upside
N/A
Price Target
$45.33
Price Target Upside
112.8%

Cash Flow

Operating Cash Flow
$-34.93M
Free Cash Flow
$-35.29M
Adj. Free Cash Flow
$-35.29M
FCF Per Share
-$0.77
OCF Per Share
-$0.77
OCF/S Ratio
-7762.7%

Income Statement

Revenue
$450K
Gross Profit
$-38K
Operating Income
$-41.76M
EBITDA
$-41.27M
Net Income
$-39.34M
EPS (Diluted)
-$0.93
Revenue / Employee
$10.23K
Profit / Employee
$-894.16K
Employees
44

© 2026 bestshares.com. All rights reserved.